home / stock / invvy / invvy news


INVVY News and Press, Indivior PLC ADR From 11/21/18

Stock Information

Company Name: Indivior PLC ADR
Stock Symbol: INVVY
Market: OTC
Website: indivior.com

Menu

INVVY INVVY Quote INVVY Short INVVY News INVVY Articles INVVY Message Board
Get INVVY Alerts

News, Short Squeeze, Breakout and More Instantly...

INVVY - Court of Appeals for the Federal Circuit Lifts Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film

SLOUGH, England , Nov. 21, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the preliminary injunction (PI) previously granted against Dr. Reddy's Laboratories (DRL) by...

INVVY - PERSERIS(TM), the First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available in the U.S. for the Treatment of Schizophrenia in Adults

SLOUGH, England and RICHMOND, Va. , Nov. 19, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that PERSERIS ™ (risperidone) for extended-release injectable suspension is now available in the United States . PERSERIS is approved by the U.S. Food and Drug ...

INVVY - Indivior Announces Upcoming Investor Events

SLOUGH, United Kingdom and RICHMOND, Va. , Nov. 6, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the following upcoming investor events: Stifel 2018 Healthcare Conference, New York City : On Tuesday, November 13 th from 9:30 a.m. to 10:10 a.m. (loca...

INVVY - Indivior PLC (INVVY) CEO Shaun Thaxter on Q3 2018 Results - Earnings Call Transcript

Indivior PLC (INVVY) Q3 2018 Results Earnings Conference Call November 01, 2018 07:00 AM ET Executives Shaun Thaxter - CEO Mark Crossley - CFO Christian Heidbreder - Chief Scientific Officer Javier Rodriguez - Chief Legal Officer Analysts Max Herrmann - Stifel Paul Cudd...

INVVY - INDIVIOR PLC ADR 2018 Q3 - Results - Earnings Call Slides

The following slide deck was published by INDIVIOR PLC ADR in conjunction with their 2018 Q3 earnings Read more ...

INVVY - Indivior PLC ADR reports Q3 results

Indivior PLC ADR ( OTCPK:INVVY ): Q3 Non-GAAP EPS of $0.08; GAAP EPS of $0.12. More news on: INDIVIOR PLC ADR, Earnings news and commentary, Healthcare stocks news, Read more ...

INVVY - Indivior Announces Nine Month and Third Quarter 2018 Results

SLOUGH, United Kingdom and RICHMOND, Va. , Nov. 1, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its financial results for the period ended September 30, 2018 , including the earnings release and investor supplement, are available on the Company's website a...

INVVY - Indivior Applauds Enactment of the SUPPORT for Patients and Communities Act of 2018

SLOUGH, England and RICHMOND, Va. , Oct. 24, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") commends Congress and the Administration for passing and enacting H.R. 6, the SUPPORT for Patients and Communities Act of 2018. We further thank the Administr...

INVVY - Trump signs STOP Act aimed at opioid crisis

President Trump signs the STOP Act today, sweeping bipartisan legislation aimed at addressing the opioid crisis. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more ...

INVVY - Indivior Provides Update on Key Business Drivers and Expectations

SLOUGH, U.K. and RICHMOND, Va. , Sept. 26, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today is providing a further update on key business drivers and expectations related to: FY 2018 net revenue and net income guidance; SUBLOCADE™ net revenue development; ...

Previous 10 Next 10